Association between copper-containing enzyme, ceruloplasmin, and anemia in chronic kidney disease, erythropoietin low responsiveness of the hemodialysis patient

Association between copper-containing enzyme, ceruloplasmin, and anemia in chronic kidney disease, erythropoietin low responsiveness of the hemodialysis patient - Association between ceruloplasmin and erythropoietin low responsiveness

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029682

Enrollment

150

Registered

2017-10-24

Start date

2017-10-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia in chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: After maintenance haemodialysis induction, continuing ESA, agreement by the free will from the person obtained about participation in this study

Exclusion criteria

Exclusion criteria: (1) It is the patient with the plan of the renal transplant within 24 weeks after registration (2) At registration, it is the patient with a malignant tumor, blood disorder or the clear hemorrhagic lesion (3) A pregnant woman, nursing mother, the patients who may be pregnant or the patients who hope for pregnancy in a research organization (4) The patients who participate in a trial (5) In addition, the patients who judged that a study responsibility physician or the study medical attendant was inappropriate

Design outcomes

Primary

Measure	Time frame
Hb concentrations and this change.	—

Secondary

Measure	Time frame
ESA dose and this change.	—

Countries

Japan

Contacts

Public ContactYuichi Sakamaki

Tachikawa Genaral Hospital Nephlorogy

sakamaki@med.niigata-u.ac.jp0258-33-3111

Outcome results